Context Therapeutics Inc. (CNTX) stock
CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.18−0.02 (-8.69%)
Close on Nov 13, 2026Market cap $16.61MP/E –Yield –
Context Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Context Therapeutics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $69.04K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $69.04K | – |
See a number that looks wrong?